Cargando…

The Association between Angiotensin II Type 1 Receptor Gene A1166C Polymorphism and Non-alcoholic Fatty Liver Disease and Its Severity

BACKGROUND Genetic predisposition may have important role in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Angiotensin II type I receptor (AGTR1) has been known to involve in the process of liver steatosis and fibrosis. This study aimed to investigate the association between AGTR1 A1166...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eshraghian, Ahad, Iravani, Shahrokh, Azimzadeh, Pedram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Association of Gastroerterology and Hepatology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040929/ https://www.ncbi.nlm.nih.gov/pubmed/30013758 http://dx.doi.org/10.15171/mejdd.2018.97

Ejemplares similares

Association between angiotensin II receptor type 1 A1166C polymorphism and chronic kidney disease
por: Chang, Hsien-Feng, et al.
Publicado: (2018)

The Role of Angiotensin II Type 1 Receptor A1166C Polymorphism in Autosomal Dominant Polycystic Kidney Disease
por: Sasidharan, Anand, et al.
Publicado: (2023)

Conformity assessment of Minimal Standard Terminology (MST) in the reports of endoscopy and colonoscopy done by internal specialists and gastroenterologists in Tehran
por: Iravani, Shahrokh, et al.
Publicado: (2011)

Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
por: Eshraghian, Ahad
Publicado: (2017)

Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population
por: Delshad, Navid, et al.
Publicado: (2016)

Angiotensin II type 1 receptor A1166C gene polymorphism and essential hypertension in Calabar and Uyo cities, Nigeria
por: Kooffreh, Mary Esien, et al.
Publicado: (2013)

Angiotensin II type-1 receptor A1166C polymorphism is associated with increased risk of ischemic stroke in hypertensive smokers
por: Szolnoki, Zoltán, et al.
Publicado: (2006)

Association of Angiotensin II Type 1 Receptor (A1166C) Gene Polymorphism and Its Increased Expression in Essential Hypertension: A Case-Control Study
por: Chandra, Sudhir, et al.
Publicado: (2014)

Association of Angiotensin-Converting Enzyme Intron 16 Insertion/Deletion and Angiotensin II Type 1 Receptor A1166C Gene Polymorphisms with Preeclampsia in South East of Iran
por: Salimi, Saeedeh, et al.
Publicado: (2011)

Coexistence of angiotensin II type-1 receptor A1166C and angiotensin-converting enzyme D/D polymorphism suggests susceptibility for small-vessel-associated ischemic stroke
por: Szolnoki, Zoltán, et al.
Publicado: (2006)

Relationship between A1166C polymorphism of angiotensin II type 1 receptor gene and arteriosclerosis: A protocol for systematic review and meta-analysis
por: Shi, Zhongping, et al.
Publicado: (2021)

Association of angiotensin ІІ type 1 receptor gene A1166C polymorphism with cancer risk: An updated meta-analysis
por: Hu, Xue, et al.
Publicado: (2019)

Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease
por: Su, Sui-Lung, et al.
Publicado: (2017)

Angiotensin receptor blockers might be protective against hepatic steatosis after liver transplantation
por: Eshraghian, Ahad, et al.
Publicado: (2023)

Evaluation of patients’ satisfaction with anesthesia in gastrointestinal endoscopic procedures in Iran
por: Iravani, Shahrokh, et al.
Publicado: (2011)

Effect of general anesthesia during GI endoscopic procedures on patient satisfaction
por: Iravani, Shahrokh, et al.
Publicado: (2012)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Iravani, Farzaneh, et al.
Publicado: (2018)

Susceptibility and Gene Interaction Study of the Angiotensin II Type 1 Receptor (AGTR1) Gene Polymorphisms with Non-Alcoholic Fatty Liver Disease in a Multi-Ethnic Population
por: Zain, Shamsul Mohd, et al.
Publicado: (2013)

Experience of 1166 Thyroidectomy without Use of Prophylactic Antibiotic
por: Lu, Qiang, et al.
Publicado: (2014)

Protective effect of early immunomodulatory treatment on ocular involvement in Behcet's disease: Historical cohort of 1166 patients
por: Tehrani-Banihashemi, Arash, et al.
Publicado: (2023)

The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review
por: Borém, Luciana M. A., et al.
Publicado: (2018)

Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas
por: Wang, Fuyu, et al.
Publicado: (2014)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
por: Lamblin, Nicolas, et al.
Publicado: (2003)

Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population()
por: Singh, Anukriti, et al.
Publicado: (2018)

Association between AGTR1 A1166C polymorphism and the susceptibility to diabetic nephropathy: Evidence from a meta-analysis
por: Zhuang, Yan, et al.
Publicado: (2018)

Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan
por: Liu, Yi, et al.
Publicado: (2022)

1166. Infection Rate in Venous–Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
por: Wang, Joseph, et al.
Publicado: (2019)

1166. Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
por: Hillenbrand, Molly, et al.
Publicado: (2020)

1166. Reverse Syphilis Screening and Adherence to The Congenital Syphilis Guidelines: Institutional Experience
por: Chatani, Brandon, et al.
Publicado: (2021)

Risk and severity of psoriasis vulgaris in relation to angiotensin II type 1 receptor gene polymorphism and metabolic syndrome
por: ElGhareeb, Mohamed Ibrahim, et al.
Publicado: (2019)

Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
por: Li, Yating, et al.
Publicado: (2018)

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
por: Yoshiji, Hitoshi, et al.
Publicado: (2009)

Effect of Interaction Between Noise and A1166C Site of AT1R Gene Polymorphism on Essential Hypertension in an Iron and Steel Enterprise Workers
por: Tong, Junwang, et al.
Publicado: (2017)

Association of ACE I/D and AGTR1 A1166C Gene Polymorphisms and Risk of Uterine Leiomyoma: A Case-Control Study
por: Keshavarzi, Farshid, et al.
Publicado: (2019)

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
por: Yang, Mengying, et al.
Publicado: (2020)

Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
por: Kim, Kwang Min, et al.
Publicado: (2021)

Test a vide des traversees dessin SI-3-76-1166-2D
por: Riboni, P, et al.
Publicado: (1977)

The effect of AT1R-1166A/C and AT2R-1675A/G polymorphisms on susceptibility to preeclampsia: A systematic review and meta-analysis
por: Quan, Yi, et al.
Publicado: (2022)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Genetic Polymorphisms in Non-alcoholic Fatty Liver Disease in Obese Egyptian Children
por: El-Koofy, Nehal M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_em7d1kdaq43jq5hs985n1one4s